Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
With a market cap of 981.29B, Eli Lilly(LLY) trades at $1,045.55. The stock has a price-to-earnings ratio of 45.31 and currently yields dividends of 57.7%.
On 2026-02-17, Eli Lilly(LLY) stock moved within a range of $1,033.82 to $1,064.33. With shares now at $1,045.55, the stock is trading +1.1% above its intraday low and -1.8% below the session's peak.
Trading volume for Eli Lilly(LLY) stock has reached 2.7M, versus its average volume of 4.38M.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,133.95 and a low of $623.78.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,133.95 and a low of $623.78.
LLY News
Why Eli Lilly’s $1 Billion AI Bet Could Reshape Drug Discovery Quick Read Eli Lilly (LLY) reported Q4 EPS of $7.54 versus $6.67 expected. Eli Lilly projected 2...
Eli Lilly (LLY) has built $1.5 billion worth of pre-launch inventory of Orforglipron, the company’s new weight-loss pill. The inventory build-up comes as Eli L...
Eli Lilly (LLY) announced topline results from the Phase 3 LIBRETTO-432 clinical trial of Retevmo as adjuvant therapy versus placebo. The study met its primary...
Analyst ratings
78%
of 32 ratingsMore LLY News
Eli Lilly continues to pursue smart acquisitions for the long term. The pharmaceutical industry can be a tricky investment. Remember Pfizer (PFE +0.38%) back i...
Eli Lilly recently reported past fourth-quarter 2025 and full-year results showing higher sales and net income, issued 2026 revenue guidance of US$80.00 billion...
Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. The RENEW-Scz-1 trial is a Phase 2 study from Eli Lilly and Company that tests...
Roche Holding AG (RHHBY) announced an update on their ongoing clinical study. Roche Steps Up in ER+ Breast Cancer: What Investors Should Know This new Genente...
Eli Lilly (LLY) has built $1.5B worth of pre-launch inventory of orforglipron, the company’s experimental oral weight-loss drug, ahead of the U.S. Food and Drug...
Eli Lilly and Company (NYSE:LLY) has stockpiled $1.5 billion worth of inventory of its experimental oral weight-loss drug, orforglipron, according to a regulato...
Eli Lilly (NYSE:LLY) announced an agreement to acquire Orna Therapeutics, a company focused on circular RNA based medicines. The deal brings Orna's in vivo cel...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.